Skin Disease Clinical Trials

22 recruitingLast updated: May 13, 2026

There are 22 actively recruiting skin disease clinical trials across 23 countries. Studies span Not Applicable, Phase 2, Phase 3, Early Phase 1, Phase 1. Top locations include New Taipei City, Taiwan, München, Germany, Berlin, Germany. Updated daily from ClinicalTrials.gov.


Skin Disease Trials at a Glance

22 actively recruiting trials for skin disease are listed on ClinicalTrialsFinder across 6 cities in 23 countries. The largest study group is Not Applicable with 4 trials, with the heaviest enrollment activity in New Taipei City, München, and Berlin. Lead sponsors running skin disease studies include C5 Biomedical, Centre for Human Drug Research, Netherlands, and BeOne Medicines.

Browse skin disease trials by phase

Treatments under study

About Skin Disease Clinical Trials

Looking for clinical trials for Skin Disease? There are currently 2 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Skin Disease trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Skin Disease clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 22 trials

Recruiting
Phase 2

Effects of Treatments on Atopic Dermatitis

DermatitisEczemaSkin Diseases+2 more
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)130 enrolled1 locationNCT01631617
Recruiting

Diagnosis and Treatment of Leishmania Infections

LeishmaniasisSkin Diseases, ParasiticEuglenozoa Infections+1 more
National Institute of Allergy and Infectious Diseases (NIAID)289 enrolled1 locationNCT00344188
Recruiting
Early Phase 1

Repurposing Dupilumab for Management of Pruritic Genetic Inflammatory Skin Disorders

Skin Diseases
Northwestern University30 enrolled1 locationNCT05649098
Recruiting
Phase 3

A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata

AlopeciaSkin DiseasesAreata Alopecia+3 more
Eli Lilly and Company595 enrolled127 locationsNCT05723198
Recruiting
Phase 1

A Study to Evaluate the Safety of BG-A3004 in Healthy Participants and Patients With Immune-Mediated Skin Diseases

Skin Diseases
BeOne Medicines98 enrolled1 locationNCT07412691
Recruiting

Clinico-biological Collection of Autoimmune, Dysimmune or Auto-inflammatory Dermatological Diseases

Skin DiseasesAutoimmune Bullous DermatosisDysimmune Dermatological Diseases+1 more
University Hospital, Toulouse800 enrolled1 locationNCT06387654
Recruiting
Phase 2

Guselkumab in the Treatment of Adults With Pyoderma Gangrenosum (PG)

Pyoderma GangrenosumWound HealSkin Diseases+2 more
Oregon Health and Science University17 enrolled2 locationsNCT06563323
Recruiting
Not Applicable

Transdiagnostic Intervention to Reduce Internalized Health-Related Stigma

CancerObesityChronic Pain+3 more
University of Florida195 enrolled1 locationNCT05561595
Recruiting

Deep Phenotyping of CIndU

Skin DiseasesAngio-Oedema and/or Urticaria
Centre for Human Drug Research, Netherlands40 enrolled3 locationsNCT07359430
Recruiting
Phase 3

A Study to Learn About the Safety and Efficacy of the Drug Oleogel-S10 in Japanese Patients With Epidermolysis Bullosa

Skin DiseasesEpidermolysis BullosaConnective Tissue Disease+7 more
Chiesi Farmaceutici S.p.A.6 enrolled6 locationsNCT06917690
Recruiting
Not Applicable

OCT Vibrography for Biomechanical Properties of Tissues

Skin DiseasesCorneaGingival Diseases
Massachusetts General Hospital90 enrolled1 locationNCT05759780
Recruiting

Dynamics of Dysbiosis in the Skin and Gut Microbiome of Burn Patients

Burn InjuriesMicrobiomeSkin Disease+1 more
Cho Yoon soo600 enrolled1 locationNCT07209007
Recruiting

Abrocitinib Taiwan Treatment Pattern and Real World Study in ATopiC Dermatitis (ATTRACT Registry)

DermatitisEczemaImmune System Diseases+3 more
Pfizer200 enrolled8 locationsNCT06353087
Recruiting

Skin Reactions Related to Thoracic Implantable Chamber Dressings

Skin Diseases
Institut Curie500 enrolled3 locationsNCT07158879
Recruiting

An Observational Study to Assess Objective Skin Pigmentation Variation.

Skin DiseasesHealthy Skin
Leiden University Medical Center600 enrolled1 locationNCT07091604
Recruiting

Multi-modal Quantitative Imaging of the Skin

Skin CancerPeripheral Arterial DiseaseAtopic Dermatitis+4 more
HJN Sverige AB/Neko Health8,000 enrolled3 locationsNCT06989216
Recruiting

The Diagnostic Accuracy of Advanced Imaging in Identifying Suspected Skin Cancer (Basal Cell Carcinoma) Around the Eyes

BCCBCC - Basal Cell CarcinomaEyelid Tumor+2 more
Vejle Hospital210 enrolled1 locationNCT06279143
Recruiting
Phase 2Phase 3

Herbal Ointment in Treating Atopic Dermatitis Topically

atopic dermatitis (eczema)Atopic DermatitisAtopic Dermatitis (AD)+4 more
En Chu Kong Hospital66 enrolled1 locationNCT06850311
Recruiting
Not Applicable

Clinical Trial Assessing Human Placental Membrane Products and Standard of Care Versus Standard of Care in Nonhealing DFUs and VLUs

Diabetes MellitusCardiovascular DiseasesDiabetes Mellitus, Type 2+16 more
C5 Biomedical177 enrolled1 locationNCT06674980
Recruiting

Fosfomycin I.v. for Treatment of Severely Infected Patients

OsteomyelitisEncephalitisSepsis+13 more
Infectopharm Arzneimittel GmbH1,000 enrolled50 locationsNCT02979951